Page last updated: 2024-09-05

lasofoxifene and ospemifene

lasofoxifene has been researched along with ospemifene in 5 studies

Compound Research Comparison

Studies (lasofoxifene)	Trials (lasofoxifene)	Recent Studies (post-2010) (lasofoxifene)	Studies (ospemifene)	Trials (ospemifene)	Recent Studies (post-2010) (ospemifene)
88	14	24	147	30	114

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lewiecki, EM	1
Biserni, A; Caruso, D; Ciana, P; Horner, D; Komm, B; Maggi, A; Ramachandran, B; Rando, G	1
Chines, AA; Komm, BS	1
Pinkerton, JV; Stanczyk, FZ	1
Pinkerton, JV; Thomas, S	1

Reviews

4 review(s) available for lasofoxifene and ospemifene

Article	Year
Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis. Journal of women's health (2002), 2009, Volume: 18, Issue:10 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Drug Therapy, Combination; Female; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Piperidines; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; RANK Ligand; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Vitamin D; Women's Health	2009
An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis. Maturitas, 2012, Volume: 71, Issue:3 Topics: Bone Density Conservation Agents; Breast; Endometrium; Female; Fractures, Bone; Humans; Indoles; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes	2012
Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:3 Topics: Atrophy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Pelvic Organ Prolapse; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Treatment Outcome; Vagina; Vaginal Diseases; Vulva; Vulvar Diseases	2014
Use of SERMs for treatment in postmenopausal women. The Journal of steroid biochemistry and molecular biology, 2014, Volume: 142 Topics: Breast Neoplasms; Clinical Trials as Topic; Dyspareunia; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Osteoporosis; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Toremifene	2014

Other Studies

1 other study(ies) available for lasofoxifene and ospemifene

Article	Year
An innovative method to classify SERMs based on the dynamics of estrogen receptor transcriptional activity in living animals. Molecular endocrinology (Baltimore, Md.), 2010, Volume: 24, Issue:4 Topics: Animals; Blotting, Western; Estradiol; Estrogens, Conjugated (USP); Female; Indoles; Mice; Mice, Inbred C57BL; Ovariectomy; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Transcription, Genetic	2010

Article

Year

An innovative method to classify SERMs based on the dynamics of estrogen receptor transcriptional activity in living animals.

Molecular endocrinology (Baltimore, Md.), 2010, Volume: 24, Issue:4

Topics: Animals; Blotting, Western; Estradiol; Estrogens, Conjugated (USP); Female; Indoles; Mice; Mice, Inbred C57BL; Ovariectomy; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Transcription, Genetic

2010